Double Blind Placebo Controlled Dose Ranging Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of GLPG0555 in Healthy Subjects.
Latest Information Update: 20 Nov 2010
At a glance
- Drugs GLPG 0555 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
Most Recent Events
- 29 Oct 2010 Secondary identifier added, as reported by ClinicalTrials.gov.
- 29 Sep 2010 New trial record